Revenue Breakdown
Composition ()
No data
Revenue Streams
Health Catalyst Inc (HCAT) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Recurring technology, accounting for 68.2% of total sales, equivalent to $52.05M. Another important revenue stream is Professional Services. Understanding this composition is critical for investors evaluating how HCAT navigates market cycles within the Software industry.
Profitability & Margins
Evaluating the bottom line, Health Catalyst Inc maintains a gross margin of 34.51%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -10.03%, while the net margin is -29.12%. These profitability ratios, combined with a Return on Equity (ROE) of -31.33%, provide a clear picture of how effectively HCAT converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, HCAT competes directly with industry leaders such as TONX and RDZN. With a market capitalization of $118.83M, it holds a significant position in the sector. When comparing efficiency, HCAT's gross margin of 34.51% stands against TONX's 65.95% and RDZN's 61.52%. Such benchmarking helps identify whether Health Catalyst Inc is trading at a premium or discount relative to its financial performance.
